In an unusual move, the Justice Department has told the U.S. Supreme Court that it wants to end a closely watched whistle-blower lawsuit against drug giant Gilead because it is "not in the public interest," according to a STAT news…
Pharmacy
The FDA failed to consistently record and evaluate necessary information to ensure drugs given the prized rare-disease designation met the legal standards required by the Orphan Drug Act, according to a new report from the Government Accountability Office.
Despite patients playing a more active role as consumers of their healthcare, they shouldn’t bear the sole burden of price-shopping for their medications.
U.S. pharmaceutical giant McKesson Corp. is moving its headquarters from San Francisco to its existing office in Las Colinas, Texas, in April, according to the San Francisco Chronicle.
Drug giant GlaxoSmithKline agreed to buy cancer treatment company Tesaro for about $5.1 billion including debt, according to CNBC.
Advertisement
A federal judge in Philadelphia has ruled that Bristol-Myers Squibb must face a whistle-blower lawsuit alleging the drugmaker knowingly underpaid rebates it owed to state Medicaid programs.
Healthcare leaders should expect changes as specialty drug spending continues to grow and health systems move to bring services closer to patients, among other trends in the new year, according to a new report from from the McKesson RxO team.
Although CVS Health's deal to buy Aetna for $69 billion closed Nov. 28, U.S. District Judge Richard Leon raised the prospect of not approving the deal during a routine legal process post-transaction, according to Reuters.
To minimize the debt burden it would assume if its $62 billion takeover of Shire is approved, Takeda Pharmaceuticals is considering a sale of up to $10 billion worth of assets, according to Nikkei Asian Review.
Twelve of the 19 largest pharmaceutical and biotech companies have at least one director serving on their board who simultaneously serves in a leadership position at a healthcare system, according to BioPharma Dive.